Viewing Study NCT00882557

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:08 PM
Ignite Modification Date: 2026-04-06 @ 12:21 PM
Study NCT ID: NCT00882557
Status: COMPLETED
Last Update Posted: 2018-02-06
First Post: 2009-04-15
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study to Evaluate Daptomycin Given During Dialysis and After Dialysis
Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None End-stage Renal Disease View
None Renal Failure Chronic Requiring Hemodialysis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None End-stage renal disease View
None hemodialysis View
None chronic renal failure View